CD P3: Double-Blind Induction
Research payments
$721,284
Through program year 2025, $721,284 in research payments was reported against CD P3: Double-Blind Induction, across 143 payments.
- Paid by (largest first)
- F. Hoffmann-La Roche AG; Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $721,284 | 143 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ricardo Rivera-Morales Miami Beach, FL Named on 19 payments
- Mark Avila Miami, FL Named on 15 payments
- Jaime Mayoral San Antonio, TX Named on 11 payments
- Osvaldo Carmona Doral, FL Named on 10 payments
- Bixuan Lin Chicago, IL Named on 10 payments
- Harinath Sheela Hamden, CT Named on 8 payments
- Allan Coates Wyoming, MI Named on 7 payments
- Jatinder Pruthi Brooklyn, NY Named on 7 payments
- Abbas Rupawala Worcester, MA Named on 7 payments
- Yaneth Trujillo Miramar, FL Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.